MedTrace Logo

Efficacy and Safety Study of Topical Capsaicin in Painful Diabetic Neuropathy

NCT00993070 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2012-05-09

No results posted yet for this study

Summary

Painful diabetic neuropathy is the most common cause of neuropathic pain. 0.075% topical capsaicin has been used to treat the pain, but there is no data in lower concentration. This is the efficacy and safety of 0.025% topical capsaicin in treatment of painful diabetic polyneuropathy.

Conditions

  • Diabetic Polyneuropathy

Interventions

DRUG

Capsaicin

0.025% topical capsaicin applied 4 times per day for 8 weeks

DRUG

placebo

vehicle gel, applied 4 times per day for 8 weeks

Sponsors & Collaborators

  • Bangkok Drug company

    collaborator UNKNOWN

  • Thammasat University

    lead OTHER

Principal Investigators

  • Kongkiat Kulkantrakorn, MD · Thammasat University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00993070 on ClinicalTrials.gov